XRXianliang Rao

Xianliang Rao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xianliang Rao has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Exploratory analysis of benzo(a)pyrene-associated osteoarthritis targets based on network toxicology and In vitro validation

    by Hongchen Zhang, Zhenyu Wang, Pingbo Chen, Xu Wang, Xianliang Rao, Chen Chen

    Benzo(a)pyrene (BaP), a widespread environmental pollutant, has been implicated in osteoarthritis (OA) development, yet underlying mechanisms remain unclear. This study aimed to elucidate the molecular mechanisms of BaP-induced OA through integrative network toxicology and experimental validation. Overlapping genes between BaP exposure and OA were identified from multiple databases (CTD, SwissTargetPrediction, NCBI, Malacards, and OMIM). Protein–protein interaction networks and enrichment analyses were performed to identify core targets and pathways. Microarray data (GSE117527) of BaP-treated human primary T lymphocytes were analyzed for differentially expressed genes. Experimental validation was conducted using human primary T lymphocytes and CHON-001 chondrocytes through Western blotting, qPCR, ELISA, and conditioned media co-culture experiments. We identified 915 overlapping genes between BaP and OA, with 17 core targets including TP53, TNF, and AKT. Transcriptomic analysis revealed the PI3K/AKT signaling pathway as a critical regulatory hub. BaP exposure significantly activated PI3K/AKT phosphorylation and upregulated TNF-α and IL-6 expression and secretion in T lymphocytes. Notably, conditioned media from BaP-stimulated T lymphocytes significantly exacerbated CHON-001 apoptosis and reduced viability compared to direct BaP exposure, demonstrating potent indirect toxicity mediated by immune cells. BaP exposure is associated with OA pathogenesis through a co-occurring network involving PI3K/AKT pathway activation and immune-mediated inflammatory responses. The discovery of T lymphocyte-mediated indirect toxicity provides novel insights into environmental pollutant-related osteoarthritis.

  • Open Access

    Low-intensity pulsed ultrasound targeting ferroptosis to mitigate joint capsule fibrosis in a rat model of post-traumatic joint contracture

    by X.L. Rao, X.L. Kan, C. Chen, Y. Wang, B.B. Zhang, L. Sigdel, J.N. Zhang, J. Mao, X.M. Li, Q.B. Zhang, et al.

    Background: Post-traumatic joint contracture (PTJC) exhibits distinctive features such as excessive collagen deposition, which is the primary cause of joint capsule fibrosis. This work aimed to examine the therapeutic impacts and the fundamental mechanisms of low-intensity pulsed ultrasound (LIPUS) on PTJC-induced fibrosis, focusing on ferroptosis-related pathways. Methods:RNA sequencing (RNA-seq) data from the Gene Expression Omnibus (GEO) database were analyzed to identify differentially expressed genes (DEGs), followed by enrichment and correlation analyses. 40 Sprague-Dawley rats were separated into 5 groups: Sham, PTJC, Natural, LIPUS, and Combined. Rats in the LIPUS and Combined groups received LIPUS stimulation, while the Combined group also received erastin injections. Hematoxylin and Eosin (H&E) staining quantified inflammatory cell infiltration; Masson’s trichrome staining measured collagen deposition. Immunofluorescence detected Cyclin D1 (fibroblast proliferation), phosphorylated nuclear factor kappa B (p-NF-κB) p65 (inflammation), solute carrier family 7 member 11 (SLC7A11)/glutathione peroxidase 4 (GPX4) (ferroptosis markers). Western blotting analyzed Collagen I/III, transforming growth factor beta 1 (TGF-β1)/Smad (fibrosis pathway). Range of motion (ROM) and joint diameter measurements evaluated contracture severity.Results:Bioinformatics analysis identified 17 ferroptosis-related and fibrosis-related target genes, withSLC7A11andGPX4selected for validation. ROM results indicated that LIPUS improved joint contracture more than the PTJC group, but the Combined group had less improvement than the LIPUS group alone. H&E and Masson’s Trichrome staining partially reversing PTJC-induced inflammation and collagen deposition. Mechanistically, immunofluorescence and Western blot indicated that LIPUS reduced fibrosis by decreasing the proliferation-related (Cyclin D1) and inflammation-related protein (p-NF-κB p65), and LIPUS inhibited PTJC-mediated initiation of TGF-β1/Smad signalling pathway and prevented inactivation of theSLC7A11/GPX4axis. Erastin counteracted LIPUS effects, confirming ferroptosis involvement.Conclusions:These findings demonstrate that LIPUS significantly mitigates PTJC-induced joint capsule fibrosis by dual mechanisms: (1) activating theSLC7A11/GPX4axis to inhibit ferroptosis and (2) suppressing TGF-β1/Smad signaling. Ferroptosis-related factors were critical as their inhibition (via erastin) exacerbated fibrosis, highlighting their role in PTJC pathogenesis.